Indian painkiller recalled over quality issues

It said batch WLD21003E of Locobile-200 produced on Feb. 4, 2021, by M/S Windlas Biotech Limited has been found falling short of quality standards in tests done by the HCMC Institute for Drug Quality Control.

The administration has instructed A My, which imported the batch, and suppliers and distributors to recall the drug.

Locobile-200 is prescribed as painkillers for certain joint conditions.

Last June the administration had ordered the recall of five drugs used to treat gastrointestinal, liver and nasal issues after they were discovered to be counterfeit.